Publication | Closed Access

Plerixafor plus granulocyte CSF can mobilize hematopoietic stem cells from multiple myeloma and lymphoma patients failing previous mobilization attempts: EU compassionate use data

Hematological MalignancyOncologyMedicineStem Cell MobilizationImmunologyHematologyStem Cell ResearchMultiple MyelomaMyelopoiesisHematopoietic Stem CellsStem CellsCell BiologyGranulocyte CsfCancer ResearchHealth Sciences